Literature DB >> 24029398

Patient perspectives on opt-out HIV screening in a Guyanese emergency department.

April Christensen1, Stephan Russ, Navindranauth Rambaran, Seth W Wright.   

Abstract

In 2007, the WHO recommended that healthcare providers in areas of a generalised HIV epidemic perform HIV testing on all adults and adolescents presenting for healthcare. Studies regarding patient acceptability of opt-out testing, however, have reported wide variation in acceptance rates. This study examines patient-reported acceptability of such testing at the emergency department (ED) of Georgetown Public Hospital Corporation, the largest public hospital in Guyana. In June 2010, a convenience sample of 343 non-critical adult patients who presented to the ED were interviewed regarding potential acceptance of opt-out HIV testing, with 75.5% (95% CI 70.5-80.0%) stating they would accept testing should it be implemented in the ED. Of 12 patient characteristics, 3 had significant differences in acceptance rates on multivariate analysis: age; gender; and previous HIV testing. In this study, potential reasons for declining testing were also examined. The highest percentage of patient agreement was with the statements 'I have had an HIV test recently enough' (84%, 95% CI 74.0-91.4%) and 'I am not at risk for HIV/AIDS' (83%, 95% CI 73.0-90.4%). The results of this study indicate that the majority of patients in this setting would accept opt-out HIV testing, although some still had concerns regarding testing. Opt-out testing in the ED has the potential to facilitate national goals for increased testing and diagnosis.

Entities:  

Year:  2012        PMID: 24029398     DOI: 10.1016/j.inhe.2012.03.001

Source DB:  PubMed          Journal:  Int Health        ISSN: 1876-3405            Impact factor:   2.473


  8 in total

Review 1.  Neuroimaging of HIV-associated neurocognitive disorders (HAND).

Authors:  Beau M Ances; Dima A Hammoud
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

Review 2.  Role of neuroimaging in HIV-associated neurocognitive disorders.

Authors:  Mary C Masters; Beau M Ances
Journal:  Semin Neurol       Date:  2014-04-08       Impact factor: 3.420

3.  Patient acceptance of HIV testing services in rural emergency departments in South Africa.

Authors:  Aditi Rao; Caitlin Kennedy; Pamela Mda; Thomas C Quinn; David Stead; Bhakti Hansoti
Journal:  South Afr J HIV Med       Date:  2020-07-22       Impact factor: 2.744

4.  Changing HCW attitudes: a case study of normalizing HIV service delivery in emergency departments.

Authors:  Aditi Rao; Victoria H Chen; Sarah Hill; Steven J Reynolds; Andrew D Redd; David Stead; Christopher Hoffmann; Thomas C Quinn; Bhakti Hansoti
Journal:  BMC Health Serv Res       Date:  2022-05-11       Impact factor: 2.908

Review 5.  A systematic review of emergency department based HIV testing and linkage to care initiatives in low resource settings.

Authors:  Bhakti Hansoti; Gabor D Kelen; Thomas C Quinn; Madeleine M Whalen; Taylor T DesRosiers; Steven J Reynolds; Andrew Redd; Richard E Rothman
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

6.  Patient and provider attitudes to emergency department-based HIV counselling and testing in South Africa.

Authors:  Bhakti Hansoti; Sarah E Hill; Madeleine Whalen; David Stead; Andy Parrish; Richard Rothman; Yu-Hsiang Hsieh; Thomas C Quinn
Journal:  South Afr J HIV Med       Date:  2017-05-31       Impact factor: 2.744

7.  Prevalence of undiagnosed HIV, hepatitis B, and hepatitis C among patients in an Indian emergency department.

Authors:  Sathishkumar Pandiselvam; Narendra N Jena; Aditi Ghatak-Roy; Nicholas Dreyer; Nehal Naik; Janice Blanchard; Kevin Davey
Journal:  J Am Coll Emerg Physicians Open       Date:  2020-12-07

Review 8.  Applying Behavioural Insights to HIV Prevention and Management: a Scoping Review.

Authors:  Alexsandra Andrawis; James Tapa; Ivo Vlaev; Daniel Read; Kelly Ann Schmidtke; Eric P F Chow; David Lee; Christopher K Fairley; Jason J Ong
Journal:  Curr HIV/AIDS Rep       Date:  2022-08-05       Impact factor: 5.495

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.